Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$2.01 +60.8%	$1.70	$1.14 ▼ $42.40	$5.59M	-3.46	514,267 shs	43.24 million shs
BJDX Bluejay Diagnostics	$1.62 +3.8%	$1.75	$1.46 ▼ $37.50	$2.42M	0.38	663,768 shs	50,948 shs
NUWE Nuwellis	$0.24 -7.9%	$0.72	$0.21 ▼ $5.84	$1.04M	0.48	3.45 million shs	2.41 million shs
SINT Sintx Technologies	$3.22 +1.9%	$2.85	$1.71 ▼ $8.60	$8.08M	0.73	939,480 shs	20,067 shs

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	0.00%	+62.10%	+20.36%	+9.84%	-89.68%
BJDX Bluejay Diagnostics	0.00%	+3.85%	+3.85%	-57.48%	-98.01%
NUWE Nuwellis	0.00%	-11.04%	-74.02%	-75.63%	-95.26%
SINT Sintx Technologies	0.00%	+2.22%	+15.41%	+16.25%	-39.70%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMIX Autonomix Medical	3.265 of 5 stars	3.5	2.0	4.0	1.7	1.3
BJDX Bluejay Diagnostics	0.5861 of 5 stars	0.0	2.0	3.8	0.0	0.6
NUWE Nuwellis	2.5524 of 5 stars	3.5	2.0	3.3	0.0	1.3
SINT Sintx Technologies	2.5428 of 5 stars	3.5	4.0	2.1	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMIX Autonomix Medical	3.00	Buy	$16.50	720.90% Upside
BJDX Bluejay Diagnostics	0.00	N/A	N/A	N/A
NUWE Nuwellis	3.00	Buy	$17.00	7,051.87% Upside
SINT Sintx Technologies	3.00	Buy	$28.00	769.57% Upside

Current Analyst Ratings Breakdown

Latest BJDX, SINT, AMIX, and NUWE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/30/2025	SINT Sintx Technologies	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$30.00 ➝ $28.00
5/13/2025	NUWE Nuwellis	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
4/29/2025	AMIX Autonomix Medical	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$5.00
4/21/2025	SINT Sintx Technologies	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$70.00 ➝ $30.00

(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	$3.29 per share	N/A
BJDX Bluejay Diagnostics	$250K	9.66	N/A	N/A	$10.34 per share	0.16
NUWE Nuwellis	$8.74M	0.12	N/A	N/A	$1.49 per share	0.16
SINT Sintx Technologies	$2.89M	2.80	N/A	N/A	$2.90 per share	1.11

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMIX Autonomix Medical	-$11.41M	-$7.47	N/A	N/A	N/A	N/A	-174.70%	-133.35%	N/A
BJDX Bluejay Diagnostics	-$7.72M	-$379.74	N/A	∞	N/A	N/A	-322.46%	-262.96%	8/13/2025 (Estimated)
NUWE Nuwellis	-$11.16M	-$18.24	N/A	N/A	N/A	-112.09%	-655.31%	-141.83%	8/12/2025 (Estimated)
SINT Sintx Technologies	-$11.02M	-$50.56	N/A	∞	N/A	-483.85%	-203.66%	-104.76%	8/4/2025 (Estimated)

Latest BJDX, SINT, AMIX, and NUWE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/29/2025	Q4 2025	AMIX Autonomix Medical	N/A	-$0.74	N/A	-$0.74	N/A	N/A
5/15/2025	Q1 2025	SINT Sintx Technologies	-$0.71	-$1.29	-$0.58	-$1.29	$0.73 million	$0.37 million
5/13/2025	Q1 2025	BJDX Bluejay Diagnostics	N/A	-$3.37	N/A	-$3.37	N/A	N/A
5/13/2025	Q1 2025	NUWE Nuwellis	-$0.45	-$0.69	-$0.24	-$0.69	$2.50 million	$1.90 million
3/31/2025	Q4 2024	BJDX Bluejay Diagnostics	-$36.00	-$112.37	-$76.37	-$112.37	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	N/A
BJDX Bluejay Diagnostics	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A
SINT Sintx Technologies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMIX Autonomix Medical	N/A	5.63	5.63
BJDX Bluejay Diagnostics	N/A	2.71	2.71
NUWE Nuwellis	N/A	2.23	1.59
SINT Sintx Technologies	N/A	3.44	3.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMIX Autonomix Medical	10.78%
BJDX Bluejay Diagnostics	18.47%
NUWE Nuwellis	3.13%
SINT Sintx Technologies	18.38%

Insider Ownership

Company	Insider Ownership
AMIX Autonomix Medical	32.40%
BJDX Bluejay Diagnostics	0.08%
NUWE Nuwellis	1.60%
SINT Sintx Technologies	0.01%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMIX Autonomix Medical	1	2.78 million	1.88 million	N/A
BJDX Bluejay Diagnostics	9	1.49 million	1.49 million	Not Optionable
NUWE Nuwellis	70	4.37 million	4.30 million	Not Optionable
SINT Sintx Technologies	40	2.51 million	2.51 million	Not Optionable

BJDX, SINT, AMIX, and NUWE Headlines

Recent News About These Companies

Sintx Technologies, Inc. (SINT) - Yahoo Finance

June 27 at 9:08 PM | finance.yahoo.com

SINTX Technologies Acquires Surgical Business Assets Of SiNAPTIC Holdings - Nasdaq

June 26 at 10:39 AM | nasdaq.com

SINTX Technologies stock jumps on deal to acquire SiNAPTIC surgical assets

June 24, 2025 | msn.com

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

June 24, 2025 | globenewswire.com

Mark Lewis Anderson Acquires 10,000 Shares of Sintx Technologies, Inc. (NASDAQ:SINT) Stock

June 24, 2025 | insidertrades.com

SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors

June 13, 2025 | tmcnet.com

Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary

May 23, 2025 | msn.com

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 22, 2025 | globenewswire.com

SiNtx Technologies Inc.

May 19, 2025 | marketwatch.com

SiNtx Technologies Inc.

May 19, 2025 | marketwatch.com

SINTX Technologies, Inc.: SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 16, 2025 | finanznachrichten.de

Mark Lewis Anderson Purchases 5,000 Shares of Sintx Technologies, Inc. (NASDAQ:SINT) Stock

May 15, 2025 | insidertrades.com

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025 | globenewswire.com

Sintx Technologies, Inc. (NASDAQ:SINT) Insider Gregg R. Honigblum Buys 10,000 Shares

May 1, 2025 | insidertrades.com

Sintx Technologies Appoints Five New Board Directors

April 8, 2025 | tipranks.com

Sintx Technologies announces changes to board, Chairman Bal to retire

April 5, 2025 | markets.businessinsider.com

SINTX Technologies Announces Strategic Changes to Board of Directors

April 3, 2025 | markets.businessinsider.com

SINTX: Peer-reviewed Study Shows Biomechanical Advantages Of Silicon Nitride In ACDF Procedures

March 21, 2025 | nasdaq.com

Maxim Group Reaffirms Their Hold Rating on Sintx Technologies (SINT)

March 21, 2025 | markets.businessinsider.com

Sintx Technologies announces publication of study on silicon nitride in ACDF

March 20, 2025 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BJDX, SINT, AMIX, and NUWE Company Descriptions

Autonomix Medical NASDAQ:AMIX

$2.01 +0.76 (+60.80%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$1.74 -0.27 (-13.43%)

As of 06/27/2025 07:59 PM Eastern

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Bluejay Diagnostics NASDAQ:BJDX

$1.62 +0.06 (+3.85%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$1.64 +0.01 (+0.93%)

As of 06/27/2025 08:00 PM Eastern

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Nuwellis NASDAQ:NUWE

$0.24 -0.02 (-7.87%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$0.23 -0.01 (-4.50%)

As of 06/27/2025 07:58 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Sintx Technologies NASDAQ:SINT

$3.22 +0.06 (+1.90%)

Closing price 06/27/2025 03:59 PM Eastern

Extended Trading

$3.08 -0.14 (-4.22%)

As of 06/27/2025 07:43 PM Eastern

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time